Biosynex SA (ALBIO) Ratios
Biosynex SA Ratios
FR:ALBIO's free cash flow for Q4 2025 was $74.00K. For the 2025 fiscal year, FR:ALBIO's free cash flow was decreased by $-1.11M and operating cash flow was $1.18M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.94 | 0.75 | 2.24 | 4.03 | 3.24 |
| Quick Ratio | 1.14 | 0.37 | 1.30 | 3.08 | 2.74 |
| Cash Ratio | 0.30 | 0.05 | 0.49 | 2.21 | 2.15 |
| Solvency Ratio | -0.23 | -0.33 | -0.10 | 0.34 | 1.09 |
| Operating Cash Flow Ratio | -0.21 | -0.12 | -0.24 | 0.13 | 1.79 |
| Short-Term Operating Cash Flow Coverage | -6.63 | -0.22 | -1.76 | 0.73 | 17.86 |
| Net Current Asset Value | $ -45.73M | $ -49.80M | $ -26.06M | $ 66.03M | $ 97.64M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.45 | 0.32 | 0.27 | 0.20 | 0.13 |
| Debt-to-Equity Ratio | 1.90 | 0.78 | 0.53 | 0.32 | 0.21 |
| Debt-to-Capital Ratio | 0.66 | 0.44 | 0.35 | 0.24 | 0.17 |
| Long-Term Debt-to-Capital Ratio | 0.65 | 0.15 | 0.32 | 0.01 | 0.15 |
| Financial Leverage Ratio | 4.20 | 2.42 | 1.94 | 1.60 | 1.60 |
| Debt Service Coverage Ratio | 1.80 | -0.31 | -0.94 | 5.24 | 17.44 |
| Interest Coverage Ratio | -1.06 | -3.40 | -14.18 | 77.57 | 384.86 |
| Debt to Market Cap | 5.52 | 3.31 | 0.71 | 0.07 | 0.15 |
| Interest Debt Per Share | 3.52 | 5.27 | 5.26 | 5.13 | 3.46 |
| Net Debt to EBITDA | 6.26 | -3.24 | -4.46 | -0.75 | -0.66 |
| Profitability Margins | |||||
| Gross Profit Margin | -3.78% | -19.76% | 52.84% | 32.82% | 47.72% |
| EBIT Margin | -27.36% | -22.92% | -37.43% | 15.44% | 36.59% |
| EBITDA Margin | 8.93% | -17.61% | -10.95% | 23.77% | 38.32% |
| Operating Profit Margin | -4.94% | -20.85% | -40.23% | 19.77% | 36.77% |
| Pretax Profit Margin | -62.29% | -37.97% | -42.67% | 12.30% | 35.80% |
| Net Profit Margin | -61.13% | -42.79% | -39.74% | 7.96% | 27.19% |
| Continuous Operations Profit Margin | -61.13% | -36.73% | -39.92% | 7.94% | 27.19% |
| Net Income Per EBT | 98.15% | 112.68% | 93.12% | 64.74% | 75.95% |
| EBT Per EBIT | 1261.70% | 182.12% | 106.08% | 62.23% | 97.36% |
| Return on Assets (ROA) | -42.72% | -22.24% | -15.28% | 6.02% | 38.67% |
| Return on Equity (ROE) | -179.39% | -53.74% | -29.68% | 9.64% | 61.98% |
| Return on Capital Employed (ROCE) | -4.37% | -19.41% | -18.62% | 17.63% | 67.73% |
| Return on Invested Capital (ROIC) | -4.09% | -13.03% | -16.91% | 11.04% | 49.96% |
| Return on Tangible Assets | -92.93% | -53.01% | -33.47% | 13.95% | 60.97% |
| Earnings Yield | -520.86% | -234.01% | -41.29% | 13.40% | 46.37% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.11 | 9.28 | 8.73 | 13.37 | 15.14 |
| Payables Turnover | 5.76 | 2.57 | 2.91 | 8.81 | 10.68 |
| Inventory Turnover | 4.32 | 1.34 | 1.15 | 3.51 | 6.42 |
| Fixed Asset Turnover | 11.19 | 6.81 | 5.78 | 22.50 | 72.66 |
| Asset Turnover | 0.70 | 0.52 | 0.38 | 0.76 | 1.42 |
| Working Capital Turnover Ratio | 35.42 | 6.99 | 1.09 | 1.53 | 4.27 |
| Cash Conversion Cycle | 92.60 | 169.70 | 234.42 | 89.99 | 46.78 |
| Days of Sales Outstanding | 71.45 | 39.32 | 41.80 | 27.29 | 24.11 |
| Days of Inventory Outstanding | 84.49 | 272.54 | 318.09 | 104.12 | 56.86 |
| Days of Payables Outstanding | 63.34 | 142.16 | 125.48 | 41.42 | 34.18 |
| Operating Cycle | 155.94 | 311.86 | 359.90 | 131.41 | 80.97 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.31 | -0.78 | -0.74 | 0.48 | 10.65 |
| Free Cash Flow Per Share | -0.46 | -1.15 | -3.79 | -2.45 | 8.80 |
| Dividend Paid and CapEx Coverage Ratio | -2.19 | -2.09 | -0.24 | 0.10 | 5.24 |
| Capital Expenditure Coverage Ratio | -2.19 | -2.09 | -0.24 | 0.16 | 5.78 |
| Operating Cash Flow Coverage Ratio | -0.10 | -0.16 | -0.15 | 0.09 | 3.11 |
| Operating Cash Flow to Sales Ratio | -0.06 | -0.10 | -0.10 | 0.03 | 0.29 |
| Free Cash Flow Yield | -76.73% | -80.86% | -54.99% | -21.50% | 40.49% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.19 | -0.43 | -2.42 | 7.46 | 2.16 |
| Price-to-Sales (P/S) Ratio | 0.12 | 0.18 | 0.96 | 0.59 | 0.59 |
| Price-to-Book (P/B) Ratio | 0.34 | 0.23 | 0.72 | 0.72 | 1.34 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.30 | -1.24 | -1.82 | -4.65 | 2.47 |
| Price-to-Operating Cash Flow Ratio | -1.90 | -1.83 | -9.27 | 23.63 | 2.04 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | -0.03 | 0.01 | -0.09 | 0.02 |
| Enterprise Value Multiple | 7.57 | -4.28 | -13.25 | 1.75 | 0.87 |
| Enterprise Value | 64.36M | 76.27M | 134.91M | 81.78M | 127.59M |
| EV to EBITDA | 7.57 | -4.28 | -13.25 | 1.75 | 0.87 |
| EV to Sales | 0.68 | 0.75 | 1.45 | 0.42 | 0.33 |
| EV to Free Cash Flow | -7.51 | -5.10 | -2.74 | -3.25 | 1.40 |
| EV to Operating Cash Flow | -10.93 | -7.54 | -13.97 | 16.54 | 1.16 |
| Tangible Book Value Per Share | -2.06 | -2.50 | -0.54 | 1.85 | 6.73 |
| Shareholders’ Equity Per Share | 1.73 | 6.18 | 9.60 | 15.84 | 16.26 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | 0.04 | 0.06 | 0.35 | 0.24 |
| Revenue Per Share | 5.08 | 7.77 | 7.17 | 19.17 | 37.07 |
| Net Income Per Share | -3.10 | -3.32 | -2.85 | 1.53 | 10.08 |
| Tax Burden | 0.98 | 1.13 | 0.93 | 0.65 | 0.76 |
| Interest Burden | 2.28 | 1.66 | 1.14 | 0.80 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.04 | 0.01 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.10 | 0.23 | 0.26 | 0.32 | 1.06 |
Currency in EUR